Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers

This module will introduce learners to the American Society of Clinical Oncology (ASCO) guideline summary on managing chemotherapy-induced peripheral neuropathy in survivors of adult cancers.

For more resources and to access the downloadable slide deck of this training, check out our GW TAP website.

Learning Objectives

After completing this self-paced free training, you will be able to:

  • Identify chemotherapy agents associated with neuropathy in adult patients with cancer and associated symptoms
  • Describe strategies to prevent chemotherapy-induced peripheral neuropathy
  • Describe strategies to treat chemotherapy-induced peripheral neuropathy that develops during or after neurotoxic chemotherapy
Course summary
Available credit: 
  • 0.50 AMA PRA Category 1 Credit™
    The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 0.50 Completion
Course opens: 
04/26/2023
Course expires: 
09/04/2028
Part of: 
Cancer Survivorship Care Guidelines for Peripheral Neuropathy, Fertility Preservation and Osteoporosis Management

Guido Cavaletti, MD

University of Milano-Bicocca

School of Medicine and Surgery

PHYSICIANS 

The George Washington University School of Medicine and Health Sciences designates this activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. 

Available Credit

  • 0.50 AMA PRA Category 1 Credit™
    The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 0.50 Completion
Please login or register to take this course.